The unquestionable therapeutic success of the anticancer drug cis-platin and its second- and third-generation analogues has triggered, during the past fifty years, the development of several metal-based potential chemotherapeutic drugs. Among all, gold complexes of the type [AuX2(dtc)] (X = Cl, Br; dtc = various dithiocarbamates), have been gaining increasing attention due to their capability to strongly inhibit tumor cells growth by exploiting mechanisms of action different from those recognized for the clinically-established platinum drugs. As known, survival of tumor cells is favored by mitochondrial changes that make death induction harder in a variety of stress conditions. These changes likely involve mitochondria, and include the inhibition of permeability transition pore (PTP) opening through a variety of kinase signaling pathways. Here, we present new biological findings for gold(III)-containing molecules showing a potent anticancer activity coupled with a peculiar selectivity toward cancer cells. The gold(III)-complexes are able to induce oxidative stress and tumor cell death favoring the PTP opening. Therefore, they target a specific hallmark of cancer cells, such as the resistance to apoptosis. These findings pave the way for a novel strategy allowing to hit crucial mechanisms that shield the neoplasms from the toxicity of many anti-tumor strategies, and identify the gold(III)-dithiocarbamates as a promising chemotherapeutic drugs.

Gold(III) complexes sensitize mitochondria of tumor cells to permeability transition

NARDON, CHIARA;
2014-01-01

Abstract

The unquestionable therapeutic success of the anticancer drug cis-platin and its second- and third-generation analogues has triggered, during the past fifty years, the development of several metal-based potential chemotherapeutic drugs. Among all, gold complexes of the type [AuX2(dtc)] (X = Cl, Br; dtc = various dithiocarbamates), have been gaining increasing attention due to their capability to strongly inhibit tumor cells growth by exploiting mechanisms of action different from those recognized for the clinically-established platinum drugs. As known, survival of tumor cells is favored by mitochondrial changes that make death induction harder in a variety of stress conditions. These changes likely involve mitochondria, and include the inhibition of permeability transition pore (PTP) opening through a variety of kinase signaling pathways. Here, we present new biological findings for gold(III)-containing molecules showing a potent anticancer activity coupled with a peculiar selectivity toward cancer cells. The gold(III)-complexes are able to induce oxidative stress and tumor cell death favoring the PTP opening. Therefore, they target a specific hallmark of cancer cells, such as the resistance to apoptosis. These findings pave the way for a novel strategy allowing to hit crucial mechanisms that shield the neoplasms from the toxicity of many anti-tumor strategies, and identify the gold(III)-dithiocarbamates as a promising chemotherapeutic drugs.
GOLD
mithocondria
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0378427414005748-main.pdf

non disponibili

Dimensione 69.42 kB
Formato Adobe PDF
69.42 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1062922
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 0
social impact